Abstract：
BACKGROUND: Airway stenting is an established procedure for treating oncological emergencies in patients with airway disorders. In patients with airway hemorrhage, respiratory conditions may worsen during stenting. Bronchial artery embolization (BAE) is useful to prevent bleeding from the bronchus. We aimed to evaluate the efficacy and safety of airway stenting after BAE in patients with malignant airway disorders.
METHODS: The medical records of all patients who underwent airway stenting following BAE at the National Hospital Organization Okayama Medical Center between 2016 and 2023 were retrospectively reviewed.
RESULTS: Thirteen procedures (11 silicone Y stents, one hybrid stent, and one self-expandable metallic stent) were performed. The median duration from BAE to airway stenting was one day (range: 1-5 days). Nine patients experienced tumor shrinkage, and none experienced severe bleeding after BAE during the stent procedure. No other major complications were associated with the stent placement. The median survival time after stenting was 169 days (range; 24-1086). No serious complications caused by BAE, such as spinal cord infarction, were observed.
CONCLUSIONS: Airway stent placement was safely performed after BAE without severe bleeding or acute respiratory failure. BAE, followed by airway stenting, is useful.
METHODS: The medical records of all patients who underwent airway stenting following BAE at the National Hospital Organization Okayama Medical Center between 2016 and 2023 were retrospectively reviewed.
RESULTS: Thirteen procedures (11 silicone Y stents, one hybrid stent, and one self-expandable metallic stent) were performed. The median duration from BAE to airway stenting was one day (range: 1-5 days). Nine patients experienced tumor shrinkage, and none experienced severe bleeding after BAE during the stent procedure. No other major complications were associated with the stent placement. The median survival time after stenting was 169 days (range; 24-1086). No serious complications caused by BAE, such as spinal cord infarction, were observed.
CONCLUSIONS: Airway stent placement was safely performed after BAE without severe bleeding or acute respiratory failure. BAE, followed by airway stenting, is useful.
摘要：
背景：气道支架置入术是治疗患有气道疾病的患者的肿瘤紧急情况的既定程序。在气道出血患者中，在支架置入期间呼吸状况可能会恶化。支气管动脉栓塞术（BAE）可用于预防支气管出血。我们旨在评估恶性气道疾病患者BAE后气道支架置入术的疗效和安全性。
方法：回顾性分析了2016年至2023年在国家医院组织冈山医学中心进行BAE后进行气道支架置入术的所有患者的病历。
结果：13个程序（11个硅胶Y支架，一个混合支架，和一个自膨式金属支架）。从BAE到气道支架置入的中位持续时间为1天(范围:1-5天)。9例患者出现肿瘤缩小,在支架手术期间，BAE术后没有发生严重出血。无其他与支架置入相关的主要并发症。支架置入后的中位生存时间为169天(范围;24-1086)。无BAE引起的严重并发症，比如脊髓梗塞，被观察到。
结论：在无严重出血或急性呼吸衰竭的BAE后安全地进行气道支架置入。BAE,然后是气道支架置入术,是有用的。
方法：回顾性分析了2016年至2023年在国家医院组织冈山医学中心进行BAE后进行气道支架置入术的所有患者的病历。
结果：13个程序（11个硅胶Y支架，一个混合支架，和一个自膨式金属支架）。从BAE到气道支架置入的中位持续时间为1天(范围:1-5天)。9例患者出现肿瘤缩小,在支架手术期间，BAE术后没有发生严重出血。无其他与支架置入相关的主要并发症。支架置入后的中位生存时间为169天(范围;24-1086)。无BAE引起的严重并发症，比如脊髓梗塞，被观察到。
结论：在无严重出血或急性呼吸衰竭的BAE后安全地进行气道支架置入。BAE,然后是气道支架置入术,是有用的。
